|
|
||||||||
J Thorac Cardiovasc Surg 2003;126:1958-1962
© 2003 The American Association for Thoracic Surgery
Evolving technology |
a Department of Cardiovascular Surgery, The Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Japan
Received for publication March 10, 2003; revisions received May 5, 2003; accepted for publication June 6, 2003.
* Address for reprints: Yukihisa Isomatsu, MD, First Department of Surgery, Yokohama City University School of Medicine 3-9 Fukuura, Kanazawa-ku, Yokohama, Japan 236-0004, Japan
isomatsu{at}med.yokohama-cu.ac.jp
OBJECTIVE: Extracardiac and lateral tunnel total cavopulmonary connection are currently 2 major options for patients with a single ventricle physiology. However, each procedure has some disadvantages over the other. We developed a new technique of extracardiac total cavopulmonary connection using a tissue-engineered graft to overcome some of the disadvantages previously associated with both the extracardiac and lateral tunnel procedures.
METHODS: Between February 2001 and October 2002, 8 patients underwent an extracardiac total cavopulmonary connection using a tissue-engineered graft in our institution. Collected bone marrow cells (1 x 108 mononucleocytes) from a patient (
1-4 mL/kg body weight) were seeded onto a biodegradable scaffold composed of polycaprolactone-polylactic acid copolymer reinforced with woven polylactic acid. After a 2- to 4-hour cultivation, the seeded scaffold was implanted as an extracardiac conduit during the total cavopulmonary connection operation.
RESULTS: There were no hospital or late deaths. At a mean follow-up of 13.4 months (range 4-25 months), all patients are alive and asymptomatic with no need for repeat surgery. A postoperative catheter examination or computed tomography showed all tissue-engineered grafts to be patent and revealed no stenosis, obstruction, or aneurysmal change in the 8 patients.
CONCLUSION: We believe that extracardiac total cavopulmonary connection using a tissue-engineered graft has the potential to overcome some of the disadvantages previously associated with extracardiac or lateral tunnel total cavopulmonary connection. However, an extended follow-up period is required to clarify the long-term clinical outcome for the tissue-engineered graft.
This article has been cited by other articles:
![]() |
K. Hayashida, K. Kanda, H. Yaku, J. Ando, and Y. Nakayama Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): Preparation of a prototype model J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 152 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lee, C.-H. Lee, S. W. Hwang, H. G. Lim, S.-J. Kim, J. Y. Lee, W.-S. Shim, and W.-H. Kim Midterm follow-up of the status of Gore-Tex graft after extracardiac conduit Fontan procedure Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1008 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Iwasa, T. Shin'oka, T. Sakamoto, Y. Nagase, H. Hasegawa, and H. Kurosawa Successful extracardiac total cavo pulmonary connection (TCPC) after external tracheobronchial stenting for tracheobronchomalacia Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 599 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gulbins, A. Pritisanac, K. Pieper, A. Goldemund, B. M. Meiser, B. Reichart, and S. Daebritz Successful Endothelialization of Porcine Glutaraldehyde-Fixed Aortic Valves in a Heterotopic Sheep Model Ann. Thorac. Surg., April 1, 2006; 81(4): 1472 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miura, Y. Isomatsu, T. Shin'oka, and H. Kurosawa Conversion to total cavopulmonary connection 9 years after closure of a large ventricular septal defect Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 129 - 131. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |